基于应变的分期作为心脏再同步治疗中的统一概念
Jürgen Duchenne1,2,3,4, Simon Calle5, Ivan Stankovic6
1Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
European heart journal. Cardiovascular Imaging
|May 26, 2025
概括
左束枝分支块 (LBBB) 隔膜张力模式预测心脏再同步治疗 (CRT) 的结果. 较低的应变阶段表明益处减少,可能是由于心肌痕,突出显示个性化CRT的LBBB模式.
科学领域:
- 心脏病学 心脏病学
- 心脏电生理学 心脏电生理学
- 医疗成像医学成像
背景情况:
- 左束枝分支块 (LBBB) 隔膜张力模式与心脏再同步治疗 (CRT) 后的左心室 (LV) 反向重塑有关.
- 需要进一步调查LBBB菌株模式的预后价值及其对CRT结果的影响,包括与保守治疗的比较.
- 了解LBBB菌株模式,心肌痕和CRT反应之间的相互作用对于优化患者选择和治疗策略至关重要.
研究的目的:
- 在接受CRT的患者中验证LBBB隔膜菌株模式的预后意义.
- 调查LBBB菌株模式对CRT接受者的临床结果和体积反应的影响.
- 探索LBBB菌株模式,心肌痕负担和接受保守治疗的CRT合格患者的CRT疗法疗效之间的关系.
主要方法:
- 一项涉及267名CRT患者的多中心研究,这些患者接受了植入前斑点追踪菌株分析.
- 155名CRT患者进行了心脏磁共振成像,以评估心肌痕.
- 与116名接受CRT治疗的患者和116名接受CRT治疗的保守治疗的患者进行比较,将LBBB隔膜菌株曲线分为五个阶段 (LBBB-0至LBBB-4).
主要成果:
- 在CRT接受者中,在LBBB阶段观察到体积反应和生存的逐步改善 (分别P < 0.001和P = 0.002).
- 心肌痕,在52%的CRT患者中存在,与LBBB阶段呈反相关性 (P = 0.003).
- LBBB阶段独立地预测了体积反应 (OR 2.30,P < 0.001) 和生存率 (HR 0.64,P = 0.038),而痕负担没有. 接受CRT治疗的患者与保守治疗的患者的生存益处显著更大,特别是在较高的LBBB阶段.
结论:
- LBBB隔膜菌株阶段作为CRT结果的独立预测器.
- 较低的LBBB菌株阶段与减弱的CRT益处有关,可能由更高的心肌痕负担介导.
- 这种LBBB菌株分类为了解LBBB病理生理学和优化CRT反应提供了有价值的框架.
更多相关视频
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
969
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
14.9K
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
47
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
47
Cardiomyopathy IV: Restrictive Cardiomyopathy
46
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
46
